Cancer Database Study Finds Mesothelioma Survival Benefit With Chemotherapy, According to Surviving Mesothelioma

Share Article

Researchers say mesothelioma patients live longer with chemotherapy, regardless of what other therapies they have.

Chemotherapy and Mesothelioma Survival

Mesothelioma Survival Benefit from Chemotherapy

Mesothelioma patients receiving some form of chemotherapy survived longer than patients who did not...

A new report out of Michigan suggests that chemotherapy maximizes the odds of survival for people with malignant pleural mesothelioma. Click here to read the details in a newly published article on the Surviving Mesothelioma website.

Scientists with Wayne State University in Detroit analyzed the cases of more than 1,600 mesothelioma patients between January 2005 and December 2009. They used data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database to determine which mesothelioma treatments produced the most promising results.

“Irrespective of surgical resection, mesothelioma patients receiving some form of chemotherapy survived longer than patients who did not, with an additional survival benefit among those patients receiving multimodal treatment,” writes Dr. Jennifer Lynn Beebe-Dimmer, lead author on the paper.

The report, published in Clinical Epidemiology, found that patients receiving chemotherapy for their mesothelioma lived a median of 7 months. Second-line chemotherapy extended survival for a median of an additional 5 months.

“Deciding which types of treatments to pursue is one of the most difficult decisions facing mesothelioma patients and families,” says Alex Strauss, Managing Editor of Surviving Mesothelioma. “Studies like this one provide vital information that can help make those decisions a little easier.”

For the full details of the analysis, see Study Finds Chemotherapy Maximizes Odds of Mesothelioma Survival, now available on the Surviving Mesothelioma website.

Beebe-DImmer, JL, et al, “Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare Investigation of treatment patterns and overall survival”, October 26, 2016, Clinical Epidemiology, eCollection, https://www.dovepress.com/mesothelioma-in-the-united-states-a-surveillance-epidemiology-and-end--peer-reviewed-article-CLEP

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website